The tuberous sclerosis complex genes in tumor development.
about
13-year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasiaHypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancersMolecular testing in lung cancer in the era of precision medicineMicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancerThe ups and downs of Wnt signaling in prevalent neurological disordersAneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and humanTuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transitionRap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinomaMammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascadeMinireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolismRheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XLTSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival.Tuberous sclerosis complex: everything old is new again.Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in miceNK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activationmTOR in renal cell cancer: modulator of tumor biology and therapeutic target.Key factors in mTOR regulation.Tuberous sclerosis complex: a brave new world?Role of AMP-activated protein kinase in cancer therapy.A child with an STK11 mutation and Sotos syndrome-like features: can STK11 mutations produce a Sotos syndrome phenocopy?p-HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis.Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling.Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression.microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1.Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells.ISOLATED UNILATERAL TUBEROUS SCLEROSIS-ASSOCIATED RENAL CYSTIC DISEASE IN A NEONATE
P2860
Q21093295-49BC0183-2E04-43B6-A92F-F044FC253381Q25255621-A8AB153F-3BD0-4B7F-8BCE-2061A25DC074Q26824599-C74FCE12-1E43-47F4-AB5D-1B806DF551B1Q28114800-D2E1F759-72B8-4195-9690-FBE34B01BF61Q28277009-B8EB745E-0D5A-43D4-9ACA-4ECEC0D8724EQ28510491-1B56A43F-74EA-4F44-9CF6-44143F8BD062Q28566030-5109A2B7-555E-47A7-89F3-C8A4ED0847D8Q28579227-BFC0FE81-572D-47CD-B657-BA820790B32EQ33559587-005E481B-13C0-4B8C-8538-BBC457B010ECQ33635798-ACFB36F4-BE1F-418E-8B15-1940D8245073Q33726390-71AA7E5F-160F-4C2F-AF07-684226DB604FQ33991599-CAE4BDE6-F6F8-42E8-AD12-6ADFFE484DC3Q34427178-B3A930DF-810C-4784-ABE7-42296597AB65Q34558911-FF0E9947-A9E3-43F5-BEAA-3E3DA5BB1E4AQ35166343-367A5E1C-6C4F-4E0B-9040-45B779D6609FQ35187265-26932425-EB9D-4050-B79C-74C477264E5CQ36680692-02DC4EC0-A440-4AB3-A45A-3FBE3760A425Q36950142-1DCA5715-0427-4CDC-BCB3-6834576DB985Q37257173-8EF4697D-EB90-4C56-95AC-D92B8119DCB2Q37451552-4937F044-8F2D-435D-BE93-F0B17817692FQ37613506-C0436A33-7E4C-418C-886B-1637E19ED920Q37678112-D03E7F0E-E7FD-4B56-9E76-A9A6F0B6332BQ38200018-7E3DDC80-FF1A-4BCC-A34C-EB6503396E7BQ38612401-ADCD56FA-C363-4C54-BE1F-F4916B7ABA56Q39610419-B534AB12-D10A-4818-A885-44E5F21F1B90Q45175810-43DB1AFA-334C-40C1-B60F-4557AA4589E2Q47098374-4252CCB2-2CC7-4A5F-A823-26B794264604Q50121276-12F1718B-9678-44FA-A95D-0CC061AE0186Q53562037-14B36F20-4E88-4137-A5AA-0AB0FC4617FBQ57523210-C0013420-CE1E-4463-AE80-E291FF63329E
P2860
The tuberous sclerosis complex genes in tumor development.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The tuberous sclerosis complex genes in tumor development.
@ast
The tuberous sclerosis complex genes in tumor development.
@en
type
label
The tuberous sclerosis complex genes in tumor development.
@ast
The tuberous sclerosis complex genes in tumor development.
@en
prefLabel
The tuberous sclerosis complex genes in tumor development.
@ast
The tuberous sclerosis complex genes in tumor development.
@en
P2860
P356
P1433
P1476
The tuberous sclerosis complex genes in tumor development.
@en
P2093
Baldwin C Mak
Raymond S Yeung
P2860
P304
P356
10.1081/CNV-200027144
P577
2004-01-01T00:00:00Z